{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T08:31:12Z","timestamp":1778747472375,"version":"3.51.4"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003130","name":"Research Foundation Flanders","doi-asserted-by":"publisher","award":["G.0291.15N"],"award-info":[{"award-number":["G.0291.15N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Research Foundation Flanders","doi-asserted-by":"publisher","award":["G051812N"],"award-info":[{"award-number":["G051812N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Research Foundation Flanders","doi-asserted-by":"publisher","award":["12I0317N"],"award-info":[{"award-number":["12I0317N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007660","name":"University of Antwerp","doi-asserted-by":"publisher","award":["TT-ZAPBOF 33049"],"award-info":[{"award-number":["TT-ZAPBOF 33049"]}],"id":[{"id":"10.13039\/501100007660","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.ejmech.2018.03.048","type":"journal-article","created":{"date-parts":[[2018,3,23]],"date-time":"2018-03-23T18:09:04Z","timestamp":1521828544000},"page":"18-26","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Optimization of the pharmacokinetic properties of potent anti-trypanosomal triazine derivatives"],"prefix":"10.1016","volume":"151","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8261-3489","authenticated-orcid":false,"given":"Irene G.","family":"Salado","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrienn","family":"Ba\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomas","family":"Verdeyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"An","family":"Matheeussen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guy","family":"Caljon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pieter","family":"Van der Veken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filip","family":"Kiekens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louis","family":"Maes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5203-4339","authenticated-orcid":false,"given":"Koen","family":"Augustyns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10110","key":"10.1016\/j.ejmech.2018.03.048_bib1","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1016\/S0140-6736(17)31510-6","article-title":"Human African trypanosomiasis","volume":"390","author":"Buscher","year":"2017","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.ejmech.2018.03.048_bib2","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1586\/14787210.2014.959496","article-title":"Treatment options for second-stage gambiense human African trypanosomiasis","volume":"12","author":"Eperon","year":"2014","journal-title":"Expert Rev. Anti Infect. Ther."},{"issue":"23","key":"10.1016\/j.ejmech.2018.03.048_bib3","doi-asserted-by":"crossref","first-page":"7174","DOI":"10.1016\/j.bmcl.2012.09.066","article-title":"Synthesis, evaluation and structure-activity relationships of triazine dimers as novel antiviral agents","volume":"22","author":"Venkatraj","year":"2012","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"9","key":"10.1016\/j.ejmech.2018.03.048_bib4","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1093\/jac\/dkt166","article-title":"Diaryltriazine non-nucleoside reverse transcriptase inhibitors are potent candidates for pre-exposure prophylaxis in the prevention of sexual HIV transmission","volume":"68","author":"Arien","year":"2013","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2018.03.048_bib5","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.antiviral.2013.11.005","article-title":"Development and in\u00a0vitro evaluation of a vaginal microbicide gel formulation for UAMC01398, a novel diaryltriazine NNRTI against HIV-1","volume":"101","author":"Grammen","year":"2014","journal-title":"Antivir. Res."},{"issue":"1\u20132","key":"10.1016\/j.ejmech.2018.03.048_bib6","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ijpharm.2014.08.054","article-title":"Development and characterization of a solid dispersion film for the vaginal application of the anti-HIV microbicide UAMC01398","volume":"475","author":"Grammen","year":"2014","journal-title":"Int. J. Pharm."},{"issue":"5","key":"10.1016\/j.ejmech.2018.03.048_bib7","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1093\/jac\/dkv501","article-title":"Resistance and cross-resistance profile of the diaryltriazine NNRTI and candidate microbicide UAMC01398","volume":"71","author":"Arien","year":"2016","journal-title":"J.\u00a0Antimicrob. Chemother."},{"issue":"49","key":"10.1016\/j.ejmech.2018.03.048_bib8","doi-asserted-by":"crossref","first-page":"34028","DOI":"10.1074\/jbc.M109.049726","article-title":"Predictive computational models of substrate binding by a nucleoside transporter","volume":"284","author":"Collar","year":"2009","journal-title":"J.\u00a0Biol. Chem."},{"issue":"6","key":"10.1016\/j.ejmech.2018.03.048_bib9","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1124\/mol.56.6.1162","article-title":"Adenosine transporters in bloodstream forms of Trypanosoma brucei brucei: substrate recognition motifs and affinity for trypanocidal drugs","volume":"56","author":"de Koning","year":"1999","journal-title":"Mol. Pharmacol."},{"issue":"19","key":"10.1016\/j.ejmech.2018.03.048_bib10","doi-asserted-by":"crossref","first-page":"5241","DOI":"10.1016\/j.bmc.2014.08.005","article-title":"From human immunodeficiency virus non-nucleoside reverse transcriptase inhibitors to potent and selective antitrypanosomal compounds","volume":"22","author":"Venkatraj","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.03.048_bib11","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.ejmech.2017.11.075","article-title":"Novel triazine dimers with potent antitrypanosomal activity","volume":"143","author":"Venkatraj","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"3","key":"10.1016\/j.ejmech.2018.03.048_bib12","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00018-007-6362-1","article-title":"Enzymatic hydroxylation of aromatic compounds","volume":"64","author":"Ullrich","year":"2007","journal-title":"Cell. Mol. Life Sci."},{"issue":"10","key":"10.1016\/j.ejmech.2018.03.048_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003253","article-title":"Identification and characterization of hundreds of potent and selective inhibitors of Trypanosoma brucei growth from a kinase-targeted library screening campaign","volume":"8","author":"Diaz","year":"2014","journal-title":"PLoS Neglected Trop. Dis."},{"issue":"6","key":"10.1016\/j.ejmech.2018.03.048_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001151","article-title":"SCYX-7158, an orally-active benzoxaborole for the treatment of stage 2 human African trypanosomiasis","volume":"5","author":"Jacobs","year":"2011","journal-title":"PLoS Neglected Trop. Dis."},{"issue":"11","key":"10.1016\/j.ejmech.2018.03.048_bib15","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1023\/B:PHAM.0000048197.77546.75","article-title":"Suramin as a chemosensitizer: oral pharmacokinetics in rats","volume":"21","author":"Ogden","year":"2004","journal-title":"Pharm. Res. (N. Y.)"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523418302915?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523418302915?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T23:37:05Z","timestamp":1565307425000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523418302915"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":15,"alternative-id":["S0223523418302915"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.03.048","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimization of the pharmacokinetic properties of potent anti-trypanosomal triazine derivatives","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.03.048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}